22.30EUR0.00%Mkt Cap: 225.53M EURP/E: 47.66Last update: 2026-05-14
Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. …
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)47.66
P/E (Forward)19.82
PEG—
P/B1.24
P/S1.33
EV/EBITDA—
EV/Revenue—
EPS (TTM)0.47
EPS (Forward)1.13
Cash Flow & Leverage
FCF Yield—
FCF Margin—
Operating CF18.85M EUR
CapEx (TTM)12.57M EUR
Net Debt/EBITDA—
Net Debt—
Technical
SMA 5022.73 (-1.9%)
SMA 20024.06 (-7.3%)
Beta0.72
S&P 52W Chg24.23%
Avg Vol (30d)2.22K
Avg Vol (10d)4.37K
Technical Indicators
RSI (14)45.0
MACD-0.1841
MACD Signal-0.0847
MACD Hist.-0.0994
BB Upper24.71 EUR
BB Middle23.11 EUR
BB Lower21.50 EUR
BB Width13.93%
ATR (14)0.9953 EUR
Vol Ratio (20d)1.34x
52W Range
20.4034% of range25.95
52W High25.95 EUR
52W Low20.40 EUR
Profitability
Gross Margin45.58%
EBITDA Margin12.02%
Profit Margin2.89%
Oper. Margin5.61%
ROE2.65%
ROA1.89%
Revenue Growth8.20%
Earnings Growth—
Balance Sheet
Debt/Equity0.09
Current Ratio—
Quick Ratio—
Book Value/Sh18.03 EUR
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateSep 1, 2017
Ownership
Shares Out.10.07M
Float—
Insiders0.08%
Institutions97.56%
Analyst Consensus
Rating—
Target (Mean)30.00 EUR
Target Range30.00 EUR – 30.00 EUR
# Analysts1
Company
Market Cap225.53M EUR
Enterprise Value—
Revenue (TTM)169.00M EUR
Gross Profit76.84M EUR
Net Income (TTM)4.87M EUR
Revenue/Share—
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
Last Price22.30 EUR
CountryFR
SectorHealthcare
IndustryMedical Devices
ISINFR0013240934